Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
China Nepstar is a prominent retail pharmacy chain based in China, specializing in the distribution of pharmaceutical products, healthcare items, and nutritional supplements. Established in 1995 and headquartered in Shenzhen, the company operates an extensive network of thousands of directly managed drugstores across major urban centers in China. It distinguishes itself by offering a combination of over-the-counter (OTC) medicines, prescription drugs, and value-added healthcare services like chronic disease management and diagnostic consultations. Formerly listed on the New York Stock Exchange, the company transitioned to a private entity in 2016. Today, it continues to be a major player in the Chinese healthcare retail sector, focusing on community-based health accessibility.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on China Nepstar.